A PHASE-II TRIAL OF MITOMYCIN, VINCRISTINE, BLEOMYCIN, AND CISPLATIN (MOBP) AS NEOADJUVANT THERAPY IN HIGH-RISK CERVICAL-CARCINOMA

被引：52
|
作者：
WEINER, SA
ARISTIZABAL, S
ALBERTS, DS
SURWIT, EA
DEATHERAGEDEUSER, K
机构：
[1] UNIV ARIZONA,DEPT OBSTET & GYNECOL,TUCSON,AZ 85721
[2] UNIV ARIZONA,DEPT RADIAT ONCOL,TUCSON,AZ 85721
[3] UNIV ARIZONA,DEPT INTERNAL MED,TUCSON,AZ 85721
[4] UNIV ARIZONA,ARIZONA CANC CTR,TUCSON,AZ 85721
来源：
GYNECOLOGIC ONCOLOGY | 1988年 / 30卷 / 01期
关键词：
D O I：
10.1016/0090-8258(88)90038-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [1] A PHASE-II TRIAL OF MITOMYCIN, VINCRISTINE, BLEOMYCIN, CISPLATINUM (MOBP) AS NEUADJUVANT THERAPY IN HIGH-RISK CERVICAL-CARCINOMA
    WEINER, S
    ARISTIZABAL, S
    ALBERTS, D
    SURWIT, E
    DEATHERAGE, K
    [J]. GYNECOLOGIC ONCOLOGY, 1986, 23 (02) : 249 - 250
  • [2] PHASE-II STUDIES OF BLEOMYCIN, CYCLOPHOSPHAMIDE, DOXORUBICIN AND CISPLATIN, AND BLEOMYCIN AND CISPLATIN IN ADVANCED CERVICAL-CARCINOMA
    EDMONSON, JH
    JOHNSON, PS
    WIEAND, HS
    MALKASIAN, GD
    CULLINAN, SA
    BROWN, LD
    MAILLIARD, JA
    JEFFERIES, JA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (02): : 149 - 151
  • [3] PHASE I/II STUDY OF NEOADJUVANT INTRAARTERIAL CHEMOTHERAPY WITH MITOMYCIN-C, VINCRISTINE, AND CISPLATIN IN PATIENTS WITH STAGE IIB BULKY CERVICAL-CARCINOMA
    PARK, SY
    KIM, BG
    KIM, JH
    LEE, JH
    LEE, ED
    LEE, KH
    PARK, KB
    LEE, BH
    KIM, KH
    [J]. CANCER, 1995, 76 (05) : 814 - 823
  • [4] NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, VINCRISTINE, AND BLEOMYCIN AND RADICAL SURGERY IN EARLY-STAGE BULKY CERVICAL-CARCINOMA
    CHANG, HC
    LAI, CH
    CHOU, PC
    TSENG, CJ
    CHANG, TC
    HSUEH, S
    HO, YS
    SOONG, YK
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (04) : 281 - 285
  • [5] A PHASE-II STUDY OF WEEKLY CISPLATIN FOLLOWED BY CISPLATIN AND IFOSFAMIDE IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA
    ROSE, PG
    PIVER, MS
    MALFETANO, JH
    BAKER, TR
    HEMPLING, RE
    RECIO, FO
    [J]. CANCER, 1993, 71 (07) : 2245 - 2249
  • [6] LONG-TERM RESULTS OF SEQUENTIAL POSTOPERATIVE TREATMENT WITH VINCRISTINE, BLEOMYCIN, MITOMYCIN-C, CISPLATIN AND RADIOTHERAPY AFTER SURGERY FOR HIGH-RISK PATIENTS WITH CERVICAL-CARCINOMA STAGE IB-IIA
    ZANETTA, G
    COLOMBO, A
    MILANI, R
    PLACA, F
    MANGIONI, C
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1995, 5 (01) : 40 - 44
  • [7] PHASE-II STUDIES OF BLEOMYCIN, IFOSFAMIDE AND CIS-PLATINUM IN ADVANCED AND RECURRENT CERVICAL-CARCINOMA
    BUXTON, EJ
    MEANWELL, CA
    MOULD, JJ
    LATIEF, T
    CHETIYAWARDANA, AD
    SPOONER, D
    TOBIAS, JS
    SOKAL, M
    ALCOCK, C
    HILTON, C
    PATERSON, M
    LUESLEY, DM
    LAWTON, FG
    REDMAN, CWE
    BLACKLEDGE, G
    [J]. ACTA ONCOLOGICA, 1988, 27 (05) : 545 - 549
  • [8] PHASE-II STUDY OF IDARUBICIN IN ADVANCED CERVICAL-CARCINOMA
    HAKES, TB
    DOUGHERTY, JB
    RAYMOND, V
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (03): : 262 - 263
  • [9] TENIPOSIDE IN RECURRENT OR ADVANCED CERVICAL-CARCINOMA - A PHASE-II TRIAL IN PATIENTS NOT PREVIOUSLY TREATED WITH CYTOTOXIC THERAPY
    PFEIFFER, P
    COLD, S
    BERTELSEN, K
    PANDURO, J
    SANDBERG, E
    ROSE, C
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 37 (02) : 230 - 233
  • [10] Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma
    Shimizu, Y
    Akiyama, F
    Umezawa, S
    Ishiya, T
    Utsugi, K
    Hasumi, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1869 - 1878
12345